In addition, we found that GSTM2, which is a detoxification enzymes, was significantly decreased in HF samples, and GSTM2 in cardiomyocytes inhibited DNA damage and eccDNA production, thereby alleviating macrophage activation and inflammation and eventually ameliorating cardiac hypertrophy. The gene discussed is GSTM2; the disease is cardiac hypertrophy.